Monday, 9 April 2018

Accepted Abstracts - WDEC 2018


Obesity | Physical Activity and Rehabilitation | Diet Managements | Nutrition Development and Research

When it comes to Diabetes, Our all parts of the body will have a antagonists activity with respect to  related Diseases and Complications.
The main problem that we want to overcome is Obesity. It can easily be tackled by maintaining the proper nutrition Food and Diet. In addition to this, the Physical activity related to weight reducing process will give a hike to this management. So, To show and demonstrate the potential information about the medical field Diabetes and Endocrinology, we are conducting a meeting which is going to be held in Rome on Aug 22-23, 2018.

Find the Accepted Abstracts under our main sessions which are follows,
1. Obesity
2. Physical Activity and Rehabilitation
3. Diet Managements
4. Nutrition Development and Research


Name : Kishor Mazumder

Affiliation: Jessore University of Science and Technology, Bangladesh

Abstract: Antidiabetic and Organ Protective Potential of hydroalcoholic extracts of Australian Lupin Cultivars of Unprocessed and Processed Seed Flours: In vitro, In vivo and In silico Approaches

Australia is the largest producer of Lupin specially sweet lupin (Lupinus angustifolius) in the world, typically producing 0.75 million tonnes per year. Due to its unique nutritional value and chemical composition, Australian sweet white lupin is attracting worldwide attention as a new and healthy ‘Super Food’. The general aim of this research is to estimate the antidiabetic potential of the Australian Lupin cultivars for processed and unprocessed flours through in vitro, in vivo and in silico bioassays with aims to determine in vitro enzyme inhibitions ( alpha amylase and alpha glucosidase), evaluate in vivo hypoglycemic and organ protective activities through biochemical and histopathlogical studies, in silico evaluation of mechanism of action of the selected metabolites of different cultivars isolated by LC-QTOF-MS/MS by exploring the α-amylase, α-glucosidase and DDP-4 inhibition activities through molecular docking analysis and ADME/T property studies also performed to measure the safety of the selected compound as drug of both processed and unprocessed lupin seed flour extracts of 9 cultivars . From In vitro, in vivo and more


Name : Saeko Imai

Affiliation: Professor, Kyoto Women's University

Abstract: The New Dietary Approach for Patients with Diabetes: How and When to Eat

Reducing the postprandial glucose level is important to decrease the risk of cardiovascular diseases even before onset of diabetes. we reported that the glucose excursions was significantly lower when the subjects ate vegetable before carbohydrate compared to the reverse regimen in both individuals with and without diabetes. In this study we explored the acute effect of the late-night-dinner and the divided-dinner on postprandial glucose levels in people with and without type 2 diabetes. Methods: Sixteen patients with type 2 diabetes and 14 healthy women were randomly assigned to this crossover study. Each participant wore a continuous glucose monitor for 5 days and consumed identical test meals from the second to the fourth day at home. Each participant consumed the test meals of breakfast at 08:00h, lunch at 13:00, and the half of the participants for more 
   

Name : Marija Glisic

Affiliation: Erasmus Medical Center, Rotterdam, Netherlands

Abstract : Association between phytoestrogens, glucose homeostasis and risk of diabetes in women: a systematic review and meta-analysis

Phytoestrogens might have advantageous effects on diabetes in women. We performed a systematic review and meta-analysis to determine the effect of phytoestrogens on glucose homeostasis and risk of type 2 diabetes (T2D) among women. Randomized clinical trials (RCT) and prospective observational studies that assessed associations of phytoestrogens (supplementation, dietary intake or biomarkers) with fasting glucose or insulin, homeostatic model assessment of insulin resistance (HOMA-IR), or with risk of T2D were included. We identified 18 RCTs (n=1,687 individuals) investigating the effect of phytoestrogen supplementation on glucose homeostasis, and 9 prospective population-based studies (n=212,796 individuals) examining the association between phytoestrogen intake and risk of T2D. As compared to placebo, phytoestrogen supplementation resulted in improvements in fasting glucose and HOMA-IR, the pooled mean differences of changes were –0.12 mmol/L (95% CI -0.20 to -0.03) and -0.24 microU/mol/L (95%CI: -0.45 to -0.03) respectively. While there was no significant decrease in insulin levels with overall phytoestrogen supplementation, pooled mean difference of changes and more
 

Tuesday, 3 April 2018








 
PULSUS Group Welcomes all the participants across the world to attend ‘World Congress on Diabetes and Endocrinology’ to be control throughout August 22-23, 2018 Rome, Italy which has prompt keynote displays, Oral talks, Poster displays and Exhibitions. WDEC 2018 strives to bring renowned scientists, Physicians, Surgeons, Professors, Instrumentalists, Medical and Industrial professions, young researchers, students and Business delegates under a single roof providing an opportunity to share the knowledge and scientific progress in the field of Diabetes and Endocrinology shaping the future research.
We welcome our Key note speaker Professor Lue Ping Zhao from University of Washington, USA.
Topic: Building and Validating a Prediction model for Pediatric Type 1 Diabetes Risk Using Next Generation Targeted Sequencing of Class II HLA Genes

Follow us for further updates,
Contact Person : John Kyle,endocrinology@pulsusmeeting.org Facebook, Twitter, LinkedIn, Word Press

Thursday, 29 March 2018

Accepted Abstracts

PULSUS Group Welcomes all the participants across the world to attend ‘World Congress on Diabetes and Endocrinology’ to be control throughout August 22-23, 2018 Rome, Italy which has prompt keynote displays, Oral talks, Poster displays and Exhibitions. WDEC 2018 strives to bring renowned scientists, Physicians, Surgeons, Professors, Instrumentalists, Medical and Industrial professions, young researchers, students and Business delegates under a single roof providing an opportunity to share the knowledge and scientific progress in the field of  Diabetes and Endocrinology shaping the future research.

The following are the speakers, Accepted Abstracts.


Name Lue Ping Zhao  
Affiliation: University of Washington, USA
Title: Building and Validating a Prediction model for Pediatric Type 1 Diabetes Risk Using Next Generation Targeted Sequencing of Class II HLA Genes

Aim: It is of interest to predict possible lifetime risk of type diabetes (T1D) in young children for recruiting high-risk subjects into longitudinal studies of effective prevention strategies.
Methods: Utilizing a case-control study in Sweden, we applied a recently developed next generation targeted sequencing (NGTS) technology to genotype  class II genes, and applied an object-oriented regression (OOR) to build and validate a prediction model for T1D.
Results: In the training set, estimated risk scores were significantly different between patients and controls (P=8.12*10-92), and the area under the curve (AUC) from the receiver operating characteristic (ROC) analysis was 0.917. Using the validation data set, and more 


Name: Chandran Saha

Affiliation: Director of Biostatistics Core, DTRC Indiana University School of Medicine, USA

Title: Program ACTIVE II: Outcomes from a Multi-State Community-Based Depression Treatment for Rural and Urban Adults with Type 2 Diabetes & The two year outcomes and cost effectiveness of a commercial weight loss program for the prevention of type 2 diabetes: a randomized control trial

In spite of solid evidence that risk for developing type 2 diabetes can be prevented by lifestyle interventions, it has been difficult to scale prevention research to address the growing public health demand. This study, conducted in Indianapolis, Indiana in 2013-16, investigated if a widely available weight management program (Weight Watchers- WW) could cost effectively achieve and sustain sufficient weight loss in persons and more 


Name: Ahdy W. Helmy

Affiliation:  Indiana University, USA

Title: Program ACTIVE II: Outcomes from a Multi-State Community-Based Depression Treatment for Rural and Urban Adults with Type 2 Diabetes & The two year outcomes and cost effectiveness of a commercial weight loss program for the prevention of type 2 diabetes: a randomized control trial

Non-alcoholic fatty liver disease (NAFLD) as a broad category, it encompasses simple steatosis to that with hepatitis, fibrosis, cirrhosis, and even hepatocellular carcinoma. NAFLD is a growing health crisis, in the US, and the West, the prevalence is 20-40%. In part, due to visceral obesity, insulin resistance, metabolic syndrome, excess lipolysis, and atherogenic dyslipidemia.
The flying fatty acids like loose cannons, and more  



Contact Person : John Kyle, endocrinology@cmesocietyconferences.com
Reach us @ Facebook, Twitter, LinkedIn, Word Press

Tuesday, 12 September 2017

WDEC 2018

About Conference


PULSUS Group Inc is a Medical publisher that adheres to stringent peer-review procedure with a view to set an example in promoting standard medical research with integrity. PULSUS Group takes pride in getting the endorsements of prestigious associations and societies like Canadian medical societies. As an ardent supporter of medical publishing, PULSUS Group closely associates with the Canadian and other international medical research associations. It publishes a wide range of medical journals that focus on medical specialties like cardiology, Integrative Medicine, Surgery and Reproductive Medicine. PULSUS group is closely associated with globally renowned academic and research societies like Canadian Society of Plastic Surgeons, Canadian Society for Aesthetic Plastic Surgery, Groupe pour l'Avancementde la Microchirurgie Canada and Canadian Society for Surgery of the Hand.

PULSUS Group Welcomes all the participants across the world to attend ‘World Congress on Diabetes and Endocrinology’ to be control throughout August 22-23, 2018 Rome, Italy which has prompt keynote displays, Oral talks, Poster displays and Exhibitions. WDEC 2018 strives to bring renowned scientists, Physicians, Surgeons, Professors, Instrumentalists, Medical and Industrial professions, young researchers, students and Business delegates under a single roof providing an opportunity to share the knowledge and scientific progress in the field of  Diabetes and Endocrinology shaping the future research.

Why to attend?

With individuals from around the globe concentrated on finding out about Diabetes Disorders and its advances in improving wellbeing; this is your best chance to achieve the biggest gathering of members from the Diabetes people group. Direct introductions, appropriate data, meet with present and potential researchers, make a sprinkle with new medication improvements, and get name acknowledgment at this 2-day occasion. Widely acclaimed speakers, the latest systems, advancements, and the most up to date refreshes in Diabetes Disorders are signs of this gathering.

Target Audiences:

  • Research scientists
  • Diabetologists
  • Endocrinologists
  • Research fellows
  • Medical practitioners
  • Scholars
  • Doctors
  • Medical and Pharma companies
  • Endocrinology and diabetes associates  
  • Medical corporates
  • Medical colleges
  • Research institutes
  • Research and developments sector professionals
  • Business entrepreneurs

Conference Highlights